In the present study, we demonstrate that therapeutic targeting of osteopontin at the NVU during the early and late acute phase of ischemic stroke improves BBB recovery and reduces both cerebral edema and infarct volume, leading to improved neurological outcome post-acute ischemic stroke. Here, SPP1 is linked to edema.